ImmunityBio Achieves World's Broadest Bladder Cancer Approval as UAE Green Lights Lead Drug

기사 요약

ImmunityBio secures UAE marketing authorization for ANKTIVA across two cancer indications, expanding treatment options for NMIBC and NSCLC.